CERo Therapeutics Provides Shareholder Update
SOUTH SAN FRANCISCO, Calif., March 11, 2026 — CERo Therapeutics Holdings, Inc. (OTCQB: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanism,…